KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLiabilities from Discontinued OperationsLiabilities from Discontinued OperationsLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Chemed (CHE) Non-Current Debt (2016 - 2026)

Chemed filings provide 16 years of Non-Current Debt readings, the most recent being $91.2 million for Q1 2026.

  • For the quarter ending Q1 2026, Non-Current Debt changed N/A year-over-year to $91.2 million, compared with a TTM value of $91.2 million through Mar 2026, changed N/A, and an annual FY2022 reading of $92.5 million, down 50.0% over the prior year.
  • Non-Current Debt hit $91.2 million in Q1 2026 for Chemed, up from $16.2 million in the prior quarter.
  • The five-year high for Non-Current Debt was $120.0 million in Q1 2022, with the low at $16.2 million in Q1 2023.
  • Median Non-Current Debt over the past 3 years was $94.2 million (2022), compared with a mean of $87.9 million.
  • The sharpest move saw Non-Current Debt tumbled 50.0% in 2022, then plummeted 86.46% in 2023.
  • Year by year, Non-Current Debt stood at $92.5 million in 2022, then crashed by 82.43% to $16.2 million in 2023, then surged by 461.23% to $91.2 million in 2026.
  • According to Business Quant data, Non-Current Debt over the past three periods came in at $91.2 million, $16.2 million, and $92.5 million for Q1 2026, Q1 2023, and Q4 2022 respectively.